News-Medical.Net

Beckman Coulter Diagnostics expands Alzheimer’s portfolio with CE-marked p-Tau217 blood test and new high-specificity research assay

Beckman Coulter Diagnostics, a global leader in clinical diagnostics and a Danaher company, today announced it received CE ...
Pharmabiz

Beckman Coulter Diagnostics receives CE-Mark under IVDR for its Access p-Tau217 assay

Beckman Coulter Diagnostics receives CE-Mark under IVDR for its Access p-Tau217 assay: Brea, California Wednesday, July 8, 2026, 11:00 Hrs [IST] Beckman Coulter Diagnostics, a glo ...

Spanish Mountain Gold Reports 100 Metres of 1.00 Gram Per Tonne Gold as Part of Its Feasibility Study Drill Program

Spanish Mountain Gold Ltd. (the " Company " or " Spanish Mountain Gold ") (TSX-V: SPA) (FSE: S3Y) (OTCQB: SPAUF) is ple ...
News-Medical.Net

n6 appoints Broad Institute Principal Investigator Aziz Al'Khafaji as Scientific Advisor, advancing AutoNorm™ as the new standard in NGS library preparation

Tec, Inc. (n6), the developer of icon96™, the first and only intelligent thermocycler platform with real-time, per-well ...

Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease Research

Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today launched the first commercial eMTBR-Tau immunoassay, now ...
360Dx

Beckman Coulter p-Tau217 Blood Test Gets CE-IVDR Mark

The test, along with other research-use tests for neurodegenerative disease, run on the Danaher subsidiary's DxI 9000 Immunoassay Analyzer system.